Stock Alert: VTv Therapeutics Nearly Doubles On Investment By MacAndrews & Forbes

By RTTNews Staff Writer   ✉   | Published:

Shares of vTv Therapeutics Inc. (VTVT) are currently surging nearly 100% on Friday morning. MacAndrews & Forbes Group revealed that it purchased 625 thousand Class A common shares of the company.

VTVT is currently trading at $4.2697, up $2.0797 or 94.96%, on the Nasdaq.

On December 10, 2020, vTv Therapeutics exercised its right to cause MacAndrews & Forbes Group LLC to purchase 625,000 shares at $1.60 per share. Total proceeds from the investment was $1.0 million.

Further, the company announced that President and CEO Stephen Holcombe and CFO Rudy Howard will continue with their respective positions until December 31, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart is preparing its pharmacies to distribute Covid-19 vaccine across the United States, once a vaccine is approved in the country. The company said it will not have any say in who can receive the vaccine, but is ready to support states once they do. The news comes as the U.S. Food and Drug Administration's vaccine advisory committee recommended the emergency use of mRNA-based COVID-19 vaccine Homfa Cabinets, manufactured by China's Shenzhen Luosi Ge Trading Co., has been recalled citing tip-over and entrapment risks for children, according to the U.S. Consumer Product Safety Commission. The recall involves about 6,375 units of Homfa HPB-087 and HPB-106 Cabinets. The HPB-087 was sold in walnut brown and the HPB-106 was sold in wood grain. Generic drug maker AvKare, inc. recalled one lot each of Sildenafil 100 mg and Trazodone 100 mg tablets due to a product mix-up, the U.S. Food and Drug Administration said in a statement. The company said the two separate products were inadvertently packaged together during bottling at a third party facility.